| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2004;35:185.)
© 2004 American Heart Association, Inc.
Original Contributions |
From the Department of Pharmacology (Y.M., Y.S., K.U.) and Photon Medical Research Center (Y.M., S.Y., T.T., S.T.), Hamamatsu University School of Medicine, Hamamatsu, and Research Division (N.O.), Sumitomo Pharmaceuticals Co Ltd, Osaka, Japan.
Correspondence to Seiji Yamamoto, MD, PhD, Photon Medical Research Center, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, 431-3192 Japan. E-mail seijiy{at}hama-med.ac.jp
| Abstract |
|---|
|
|
|---|
Methods Cortical neurons were prepared from 1-day old rats, and cultured on the glass-based dishes. Glutamate-induced neuronal death was assessed by staining the cells with propidium iodide. Morphological changes in the neurons were observed with a video-enhanced contrast-differential interference contrast microscope. The intracellular calcium concentration ([Ca2+]i) and the intracellular pH (pHi) were measured by fluorescence imaging with a confocal laser microscope using fluo-3/acetoxymethylester (AM) and 2', 7'-bis-2-carboxy-ethyl-5(6)-carboxyfluorescein (BCECF)/AM as a fluorescent dye, respectively.
Results SM-20220 (0.3 to 30 nmol/L) dose-dependently attenuated glutamate (300 µmol/L)-induced neuronal death over a period of 6 hours, and inhibited the acute cellular swelling following glutamate (500 µmol/L) exposure. Dual peaks of [Ca2+]i rise were observed at 5 and 12 minutes after glutamate (500 µmol/L) exposure, followed by a persistent rise. SM-20220 suppressed the persistent [Ca2+]i increase. SM-20220 inhibited intracellular acidification following glutamate (500 µmol/L) exposure. All of the events induced by glutamate were also inhibited by the N-methyl-D-aspartate receptor antagonist, MK-801, indicating the death process was excitotoxicity.
Conclusions NHE inhibitor is neuroprotective through inhibition of both persistent [Ca2+]i increase and acidification in excitotoxicity.
Key Words: excitotoxicity glutamates Na+/H+ exchanger neuronal death rats
| Introduction |
|---|
|
|
|---|
In the brain, the Na+/H+ exchanger (NHE), a ubiquitous protein, is essential for intracellular pH (pHi) regulation under both physiological and pathological conditions.8 While glutamate receptors effectively increase intracellular Na+, the intracellular acidosis activates the NHE to extrude the proton from the cell, resulting in the Na+ influx9,10 followed by cellular swelling. The increase in Na+ influx reverses the Na+/Ca2+ exchange system to protrude Na+, and then leads to Ca2+ overload.9,1113 This can deteriorate the process of neuronal death, whereas it remains controversial.14 Thus, inhibition of the NHE should improve not only Na+-mediated cellular swelling but also Ca2+ overload, and thereby, cell death. Although recent reports have indeed demonstrated the protective effects of NHE inhibitors on ischemia/reperfusion brain injury in animal models,1517 the mechanism underlying the neuroprotection remains unclear.
We therefore examined the effects of a newly synthesized selective NHE inhibitor, SM-20220, (N-[aminoiminomethyl]-1-methyl-1H-indole-2-carboxamide methanesulfonate), on glutamate-induced neuronal death, Ca2+ overload, cellular swelling, and intracellular acidification in rat-cultured cortical neurons. SM-20220 has very little effect against the Na+, K+, and Ca2+ (L and N type) channels, and
-amino-3-hydroxy-5-methyl-4-isoxazoleprooionate (AMPA), kainate, and N-methyl-D-aspartate (NMDA) receptors even at a concentration of 10 µmol/L in rat neurons that has been confirmed by a commercially available screening service (MDS PanLabs enzyme and radioligand binding assays) (Table).2932
|
| Materials and Methods |
|---|
|
|
|---|
Cortical neurons were prepared from 1-day-old Wistar rats as described in our publication.18 In brief, after ether anesthesia, the cortices were removed, dissected out, dissociated, and plated on collagen-coated culture dishes (Iwaki Glass Base Dish, Asahi Techno Glass Co). The culture medium was a mixture of Dulbeccos modified Eagle medium (50%; Gibco No. 31600, Invitrogen Japan K.K.), Hanks balanced salt solution (25%; Gibco No. 11201), and horse serum (25%). Glucose and 2-[4-(2-hydroxyethyl)-1-piperazinyl]ethanesulfonic acid (HEPES) were added at a final concentration of 36.1 mmol/L and 23.7 mmol/L, respectively. The pH of the medium was adjusted to 7.2. Penicillin-G, streptomycin, and 10 µmol/L cytosine arabinoside were added to the culture medium. The cells were maintained at 37°C with a 5% CO2-containing atmosphere for 10 to 14 days, then used for experiments.
Induction of Excitotoxicity and Assessment of Neuronal Death
Glutamate excitotoxicity was induced in primary cultures as described.19 After washing the cultures with artificial cerebrospinal fluid (aCSF)NaCl, 140 mmol/L; KCl, 5 mmol/L; MgCl2, 1.2 mmol/L; CaCl2, 2mmol/L; glucose, 10 mmol/L; and HEPES, 10 mmol/L (pH 7.2)they were incubated at 37°C for 6 hours with aCSF-containing glutamate (300 µmol/L). In some experiments, SM-20220 or MK-801, an NMDA receptor antagonist, was added to the aCSF 20 minutes before glutamate exposure.
The mortality of the cultures was assayed by using propidium iodide (PI),19 which does not penetrate viable cells but enters injured cells, yielding the red PI staining. At the end of glutamate exposure, the cultures were incubated with aCSF-containing PI (3 µmol/L) at 37°C for 15 minutes. To assess the neuronal death, we employed a differential interference contrast (DIC) microscope (Axiovert 10, Zeiss) with a 20x DIC objective lens and fluorescence optics (excitation at 515 nm, emission at 620 nm). The DIC image of the cells and the fluorescence image of PI were obtained with a 3-chip chilled color charge-coupled device (CCD) camera (C5810, Hamamatsu Photonics,). The percentage of neuronal death was calculated by counting the number of all neurons (in the DIC mode) and that of the neurons stained with PI (in the fluorescence mode). Under the microscope, 3 fields (30 to 50 neurons per field) were chosen at random in each dish.
Morphological Observation
The morphological changes of the neurons were examined under the DIC microscope. The DIC image was obtained with a CCD camera (C6489, Hamamatsu Photonics), contrast-enhanced digitally in real time by using an image processor (ARGUS 20, Hamamatsu Photonics), then monitored, and recorded on a videotape. A dish containing cells was superfused with aCSF (34°C) for 5 minutes (0.5 mL/min), followed by superfusion with aCSF-containing glutamate (500 µmol/L) combined with drugs or vehicles. To analyze the cellular swelling, the area of the cell was measured before application of glutamate to establish the baseline value, and subsequently calculated as a percentage of the baseline.
Measurement of [Ca2+]i and pHi
[Ca2+]i was measured by fluorescence imaging with fluo-3 or Calcium Orange-5N, and pHi with BCECF [2', 7'-bis-2-carboxy-ethyl-5-(6)-carboxyfluorescein].20 Neurons were rinsed 3 times and incubated at 37°C with aCSF-containing fluo-3/acetoxymethylester (AM) (4.4 µmol/L) for 20 minutes or Calcium Orange-5N/AM (5 µmol/L) for 30 minutes, or with BCECF/AM (1 µmol/L) for 10 minutes. After 3 rinses with aCSF, the cells were observed with a microscope (IX 70, Olympus) equipped with a confocal scanner of a microlens-attached Nipkow-disk (CSU-10, Yokokawa Electric Co). After recording the control images, the neurons were exposed to aCSF (34°C)-containing 500 µmol/L, and the fluorescence images were taken for 20 minutes. Since the continuous perfusion under the confocal microscope interfered the focus, the neurons were exposed to glutamate by dropping aliquot (1 µL) out of the observation field. The pilot study revealed that the time for diffusion was about 2 minutes. After recording the control data, fluorescence images of the neurons were taken for 20 minutes. In some experiments, drugs or vehicles were added to the medium 20 minutes before glutamate application.
Chemicals
MK-801 and PI were purchased from Sigma. Fluo-3/AM and BCECF/AM were obtained from Dojindo, and Calcium Orange-5N/AM obtained from Molecular Probe. SM-20220 synthesized at the Sumitomo Pharmaceuticals Research Center was dissolved in 8% polyethyleneglycol 400 (PEG) just before the experiments, and used at the final concentration of 0.008% PEG.
Statistical Analysis
Data are presented as the mean±SD and evaluated using Students t test or 1-way analysis of variance (ANOVA). Group comparisons were made using Dunnetts multiple comparison test. A P value <0.05 was considered significant.
| Results |
|---|
|
|
|---|
|
SM-20220 Inhibits Glutamate-Induced Cellular Swelling
After glutamate (500 µmol/L) exposure, cellular swelling developed over 15 minutes (Figure 2a). The area of the neuron gradually increased to 111.9±9.0% of the baseline in 15 minutes (Figure 2b). MK-801 and SM-20220 (30 nmol/L) completely suppressed cellular swelling (Figure 2b). Neither aCSF nor SM-20220 (30 nmol/L) alone induced morphological changes (data not shown).
|
SM-20220 Suppresses Glutamate-Induced Increase in [Ca2+]i
SM-20220 alone (up to 30 nmol/L) did not affect [Ca2+]i in the neurons (data not shown). Neurons stained with fluo-3 were exposed to 500 µmol/L glutamate by dropping aliquot (see Materials and Methods), and observed every 20 sec under a confocal microscope. Figure 3a shows the percent change in fluorescence intensity. Glutamate (500 µmol/L) alone induced a dual peak, ie, the first transient increase at 5 minutes and the second peak at 12 minutes, followed by a persistent rise lasting until the end of the observation. SM-20220 (30 nmol/L) did not suppress the first peak, whereas MK-801 (20 µmol/L) suppressed both (Figure 3a).
|
Since some studies have reported that fluo-3 (Kd=390 nmol/L), a high-affinity calcium indicator, underestimates increase in [Ca2+]i by glutamate,21,22 we also examined changes in [Ca2+]i using a low-affinity calcium indicator, Calcium Orange-5N (Kd=20 µmol/L). The result indicated a comparable time course to that using fluo-3 with respect to the persistent [Ca2+]i increase after glutamate application. However, the indicator did not achieve the first phase and fluctuation, seen with fluo-3, due to the low-affinity. SM-20220 significantly suppressed the persistent [Ca2+]i increase (Figure 3b).
SM-20220 showed significant and dose-dependent prevention of a rise in [Ca2+]i examined with fluo-3 15 minutes after glutamate exposure (Figure 4).
|
SM-20220 Improves Glutamate-Induced Acidification
Glutamate (500 µmol/L) gradually evoked a decrease in the fluorescence intensity of BCECF, which reached 43.7±9.1% of the basal value by the end of the observation (Figure 5a), indicating a decrease in pHi. MK-801 significantly suppressed the reduction of fluorescence intensity during the observation period (Figure 5a). Although SM-20220 (30 nmol/L) similarly suppressed it until 10 minutes after glutamate exposure, as the observation period progressed, its suppressive effect was less than that by MK-801 (Figure 5a). Figure 5b shows that SM-20220 (0.3 to 30 nmol/L) significantly inhibited the decrease in fluorescence intensity 15 minutes after glutamate exposure. MK-801 (20 µmol/L) also significantly inhibited intracellular acidification (16.4±9.2% change from basal value). Neither aCSF alone (Figure 5) nor SM-20220 (30 nmol/L) alone (data not shown) affected fluorescence intensity of BCECF, except for photobleaching.
|
| Discussion |
|---|
|
|
|---|
In the earlier study, the IC50 of SM-20220 for inhibition of the NHE in neurons and astrocytes was 5 and 20 nmol/L, respectively.23 In our present study, the lower concentrations of SM-20220 significantly reduced the neuronal death and acidification, indicating that SM-20220 mainly affected the neurons and produced the neuroprotection. However, we cannot exclude the possibility that some effects of SM-20220 may be mediated through astrocytes, since our culture contains 30% to 50% neurons and 50% to 70% astrocytes. For optimum imaging, we used different concentrations of glutamate, ie, 300 µmol/L for the excitotoxicity study and 500 µmol/L for imaging [Ca2+]i and pHi. Since, in the present study, the effects of glutamate even in the different concentrations were completely inhibited by MK-801, the glutamate-induced events, including neuronal death, cellular swelling, and change in [Ca2+]i and pHi, must be mediated through the NMDA receptor. These results justify our conclusion even in the experiments conducted using the small different concentrations of glutamate.
Our results showed that glutamate-induced cellular swelling was inhibited by SM-20220, providing the evidence for activation of the NHE during the process. After glutamate exposure, intracellular acidosis activates the NHE to extrude the proton from the cell, resulting in the Na+ influx.9,10 The accumulation of Na+ increases the intracellular osmolarity, causing water influx, ie, cell volume increases.24,25 In addition, Ca2+ influx through NMDA receptor activation may also play a role in the cellular swelling, since MK-801 inhibited it. Glutamate-induced cellular swelling initially occurred by Na+ and Ca2+ influx through the glutamate receptor,5 and Na+ and Ca2+ are mainly counteracted by the energy-consuming ATP-dependent Na+/K+ adenosine triphosphatase26 and by the ATP-dependent Ca2+ pump,27 respectively. However, the energy failure due to mitochondrial dysfunction induced by Ca2+ influx7 impairs these energy-consuming systems and leads to further cellular swelling.28 Since the activated NHE also induces Ca2+ influx as discussed below, it must contribute to the energy failure as well as the cellular swelling. Irrespective of the mechanism, the cellular swelling eventually leads to the rupture of the cell membrane and then provides the neuronal death. Thus, suppression of the cellular swelling via NHE can be neuroprotective.
It is well established that Ca2+ overload is a major mechanism of ischemic cell damage.5 In this study, glutamate induced a dual peak in [Ca2+]i observed with fluo-3; one peak represented the first transient increase, the other the second increase followed by a persistent rise. The initial rise can be induced by NMDA receptor activation, because MK-801 suppressed it, and because the NMDA receptor is much more permeable to Ca2+ among the glutamate receptors.5 The second increase followed by persistent increase in [Ca2+]i can be mediated not only by the NMDA receptor but also by the NHE, since both SM-20220 and MK-801 suppressed it. Conceivably the NHE activation due to intracellular acidosis results in the Na+ influx,9,10 which reverses the Na+/Ca2+ exchange to protrude Na+, may worsen the Ca2+ overload, and leads to persistent [Ca2+]i increase.9,1113 Given that the NHE inhibitor could reduce neuronal death, the suppression of persistent increase in [Ca2+]i, demonstrated by using the different types of calcium dye, may be important in preventing the excitotoxic neuronal death.
In the brain, NHE is essential for intracellular pHi regulation under both physiological and pathological conditions.8 The intracellular acidosis activates the NHE system to extrude the protons from the cell.9,10 It is therefore expected that the NHE inhibitor may worsen acidosis following glutamate exposure. However, in our present study, the NHE inhibitor did not worsen but, rather, partially improved acidification following glutamate application. The possible explanations for the unexpected result are as follows: (1) the glutamate-induced acidification is mediated by energy failure7; (2) the energy failure is caused by mitochondrial dysfunction through Ca2+ overload7; and (3) the reduction of Ca2+ overload by NHE inhibition might restore the mitochondrial function that consequently improves intracellular acidification. This is supported by our results; the NMDA receptor antagonist inhibited both Ca2+ overload and intracellular acidosis following glutamate exposure, although it has no direct effect on pHi regulation.
In conclusion, SM-20220, an NHE inhibitor, suppressed neuronal death and cellular swelling induced by glutamate through inhibition of both Ca2+ influx and acidification in the neurons. The activation of the NHE system may enhance the progress of cerebral damage and edema after cerebral ischemia. The results in the present study can translate the beneficial effects of NHE inhibitors in vivo with respect to the reduction of cerebral infarction and brain swelling.17 Thus, the blockade of NHE is likely to be of therapeutic benefit in the treatment of ischemic stroke.
| Acknowledgments |
|---|
Received March 31, 2003; revision received August 28, 2003; accepted September 19, 2003.
| References |
|---|
|
|
|---|
2. Choi DW. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 1988; 11: 465469.[CrossRef][Medline] [Order article via Infotrieve]
3. Dubinsky JM, Rothman SM. Intracellular calcium concentrations during "chemical hypoxia" and excitotoxic neuronal injury. J Neurosci. 1991; 11: 25452551.[Abstract]
4. Randall RD, Thayer SA. Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons. J Neurosci. 1992; 12: 18821895.[Abstract]
5. Choi DW. Excitotoxic cell death. J Neurobiol. 1992; 23: 12611276.[CrossRef][Medline] [Order article via Infotrieve]
6. Hartley Z, Dubinsky JM. Changes in intracellular pH associated with glutamate excitotoxicity. J Neurosci. 1993; 13: 46904699.[Abstract]
7. Wang GJ, Randall RD, Thayer SA. Glutamate-induced intracellular acidification of cultured hippocampal neurons demonstrates altered energy metabolism resulting from Ca2+ loads. J Neurophysiol. 1994; 72: 25632569.
8. Yao H, Ma E, Gu XQ, Haddad GG. Intracellular pH regulation of CA1 neurons in Na+/H+ isoform 1 mutant mice. J Clin Invest. 1999; 104: 637645.[Medline] [Order article via Infotrieve]
9. Raley-Susman KM, Cragoe EJ Jr, Sapolsky RM, Kopito RR. Regulation of intracellular pH in cultured hippocampal neurons by and amiloride-insensitive Na+/H+ exchanger. J Biol Chem. 1991; 266: 27392745.
10. Trudeau LE, Parpura V, Haydon PG. Activation of neurotransmitter release in hippocampal nerve terminals during recovery from intracellular acidification. J Neurophysiol. 1999; 81: 26272635.
11. Lipton P, Lobner D. Mechanism of intracellular calcium accumulation in the CA1 region of rat hippocampus during anoxia in vitro. Stroke. 1990; 21 (suppl): III60III64.[Medline] [Order article via Infotrieve]
12. Stys PK, Waxman SG, Ransom BR. Na+-Ca2+ exchanger mediates Ca2+ influx during anoxia in mammalian central nervous system white matter. Ann Neurol. 1991; 30: 375380.[CrossRef][Medline] [Order article via Infotrieve]
13. Khodorov B, Pinelis V, Golovina V, Fajuk D, Andreeva N, Uvarova T, Khaspekov L, Victorov I. On the origin of a sustained increase in cytosolic Ca2+ concentration after a toxic glutamate treatment of the nerve cell culture. FEBS Lett. 1993; 324: 271273.[CrossRef][Medline] [Order article via Infotrieve]
14. Hoyt KR, Arden SR, Aizenman E, Reynolds IJ. Reverse Na+/Ca+ exchange contributes to glutamate-induced intracellular Ca2+ concentration increases in cultured rat forebrain neurons. Mol Pharmacol. 1998; 53: 742749.
15. Kuribayashi Y, Horikawa N, Itoh N, Kitano M, Ohashi N. Delayed treatment of Na+/H+ exchange inhibitor SM-20220 reduces infarct size in both transient and permanent middle cerebral artery occlusion in rats. Int J Tissue React. 1999; 21: 2933.[Medline] [Order article via Infotrieve]
16. Phillis JW, Estevez AY, Guyot LL, ORegan MH. 5-(N-ethyl-N-isopropyl)-amiloride, an Na+-H+ exchange inhibitor, protects gerbil hippocampal neurons form ischemic injury. Brain Res. 1999; 839: 199202.[CrossRef][Medline] [Order article via Infotrieve]
17. Suzuki Y, Matsumoto Y, Ikeda Y, Kondo K, Ohashi N, Umemura K. SM-20220, a Na+/H+ exchanger inhibitor: effects on ischemic brain damage through edema and neutrophil accumulation in a rat middle cerebral artery occlusion model. Brain Res. 2002; 945: 242248.[CrossRef][Medline] [Order article via Infotrieve]
18. Nagai N, Yamamoto S, Tsuboi T, Ihara H, Urano T, Takada Y, Terakawa S, Takada A. Tissue-type plasminogen activator is involved in the process of neuronal death induced by oxygen-glucose deprivation in culture. J Cereb Blood Flow Metab. 2001; 21: 631634.[Medline] [Order article via Infotrieve]
19. Sattler R, Charlton MP, Hafner M, Tymianski M. Determination of the time course and extent of neurotoxicity at defined temperatures in cultured neurons using a modified multiwell plate fluorescence scanner. J Cereb Blood Flow Metab. 1997; 17: 455463.[CrossRef][Medline] [Order article via Infotrieve]
20. Rink TJ, Tsien RY, Pozzan T. Cytoplasmic pH and free Mg2+ in lymphocytes. J Cell Biol. 1982; 95: 189196.
21. Hyrc K, Handran SD, Rothman SM, Goldberg MP. Ionized intracellular calcium concentration predicts excitotoxic neuronal death: observation with low-affinity fluorescent calcium indicators. J Neurosci. 1997; 17: 66696677.
22. Stout AK, Reynolds IJ. High-affinity calcium indicators underestimate increase in intracellular calcium concentration associated with excitotoxic glutamate stimulations. Neuroscience. 1999; 89: 91100.[CrossRef][Medline] [Order article via Infotrieve]
23. Kuribayashi Y, Itoh N, Kitano M, Ohashi N. Cerebroprotective properties of SM-20220, a potent Na+/H+ exchange inhibitor, in transient cerebral ischemia in rats. Eur J Pharmacol. 1999; 383: 163168.[CrossRef][Medline] [Order article via Infotrieve]
24. Kempski O, Staub F, Jansen M, Schodel F, Baethmann A. Glial swelling during extracellular acidosis in vitro. Stroke. 1988; 19: 385392.
25. Jakubovicz DE, Klip A. Lactic acid-induced swelling in C6 glial cells via Na+/H+ exchange. Brain Res. 1989; 485: 215224.[CrossRef][Medline] [Order article via Infotrieve]
26. Hansen AJ. Effect of anoxia on ion distribution in the brain. Physiol Rev. 1985; 65: 101148.
27. Miller RJ. The control of neuronal Ca2+ homeostasis. Prog Neurobiol. 1991; 37: 255285.[CrossRef][Medline] [Order article via Infotrieve]
28. Budd SL. Mechanism of neuronal damage in brain hypoxia/ischemia: focus on the role of mitochondrial calcium accumulation. Pharmacol Ther. 1998; 80: 203229.[CrossRef][Medline] [Order article via Infotrieve]
29. Sills MA, Fagg G, Pozza M, Angst C, Brundish DE, Hurt SD, Wilusz EJ, Williams M. [3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain. Eur J Pharmacol. 1991; 192: 1924.[CrossRef][Medline] [Order article via Infotrieve]
30. Siegel BW, Sreekrishna K, Baron BM. Binding of the radiolabeled glycine site antagonist [3H]MDL 105519 to homomeric NMDA-NR1a receptors. Eur J Pharmacol. 1996; 312: 357365.[CrossRef][Medline] [Order article via Infotrieve]
31. Goldman ME, Jacobson AE, Rice KC, Paul SM. Differentiation of [3H]phencyclidine and (+)-[3H]SKF-10047 binding sites in rat cerebral cortex. FEBS Lett. 1985; 190: 333336.[CrossRef][Medline] [Order article via Infotrieve]
32. Schoemaker H, Allen J, Langer SZ. Bindings of [3H]ifenprodil, a novel NMDA antagonist, to a polyamine-sensitive site in the rat cerebral cortex. Eur J Pharmacol. 1990; 176: 249250.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
K. Nakamura, M. Kamouchi, T. Kitazono, J. Kuroda, R. Matsuo, N. Hagiwara, E. Ishikawa, H. Ooboshi, S. Ibayashi, and M. Iida Role of NHE1 in calcium signaling and cell proliferation in human CNS pericytes Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1700 - H1707. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hom, M. A. Fleegal, R. D. Egleton, C. R. Campos, B. T. Hawkins, and T. P. Davis Comparative changes in the blood-brain barrier and cerebral infarction of SHR and WKY rats Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2007; 292(5): R1881 - R1892. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Numakawa, T. Matsumoto, D. Yokomaku, T. Taguchi, E. Niki, H. Hatanaka, H. Kunugi, and T. Numakawa 17{beta}-Estradiol Protects Cortical Neurons Against Oxidative Stress-Induced Cell Death through Reduction in the Activity of Mitogen-Activated Protein Kinase and in the Accumulation of Intracellular Calcium Endocrinology, February 1, 2007; 148(2): 627 - 637. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yamamoto, S. Yamamoto, T. Hirano, S. Li, M. Koide, E. Kohno, M. Okada, C. Inenaga, T. Tokuyama, N. Yokota, et al. Monitoring of Singlet Oxygen Is Useful for Predicting the Photodynamic Effects in the Treatment for Experimental Glioma Clin. Cancer Res., December 1, 2006; 12(23): 7132 - 7139. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamamuro, M. Yoshimura, M. Nakayama, K. Abe, M. Shono, S. Suzuki, T. Sakamoto, Y. Saito, K. Nakao, H. Yasue, et al. Direct Effects of Aldosterone on Cardiomyocytes in the Presence of Normal and Elevated Extracellular Sodium Endocrinology, March 1, 2006; 147(3): 1314 - 1321. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |